chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Nausea
Clinical narrative: Severe nausea; dizziness; Body aches; Chills; This is a spontaneous report received from a contactable consumer (patient herself). A 50-year-old female patient (not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: el3246), via an unspecified route of administration on Arm Left on 20Jan2021 13:45 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were reported as none. The patient previously took codeine and experienced allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 23Jan2021 21:45, the patient experienced severe nausea, dizziness, body aches and chills. The patient was not diagnosed with COVID-19, prior to vaccination. The patient has been tested for COVID-19 since the vaccination. The patient underwent lab tests and procedures which included polymerase chain reaction: Negative on 24Jan2021 (COVID test type post vaccination: Nasal Swab). The events result in emergency room/department or urgent care visit. The patient did not receive any treatment for the events. The events were assessed as non-serious by the reporter. The outcome of the events was reported as recovered on an unspecified date in Jan2021.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, SARS-CoV-2 test negative, Tremor
Clinical narrative: Severe nausea; dizziness; Body aches; Chills; This is a spontaneous report received from a contactable consumer (patient herself). A 50-year-old female patient (not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: el3246), via an unspecified route of administration on Arm Left on 20Jan2021 13:45 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were reported as none. The patient previously took codeine and experienced allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 23Jan2021 21:45, the patient experienced severe nausea, dizziness, body aches and chills. The patient was not diagnosed with COVID-19, prior to vaccination. The patient has been tested for COVID-19 since the vaccination. The patient underwent lab tests and procedures which included polymerase chain reaction: Negative on 24Jan2021 (COVID test type post vaccination: Nasal Swab). The events result in emergency room/department or urgent care visit. The patient did not receive any treatment for the events. The events were assessed as non-serious by the reporter. The outcome of the events was reported as recovered on an unspecified date in Jan2021.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Dizziness, Nausea, Pain, Polymerase chain reaction
Clinical narrative: Severe nausea; dizziness; Body aches; Chills; This is a spontaneous report received from a contactable consumer (patient herself). A 50-year-old female patient (not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: el3246), via an unspecified route of administration on Arm Left on 20Jan2021 13:45 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were reported as none. The patient previously took codeine and experienced allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 23Jan2021 21:45, the patient experienced severe nausea, dizziness, body aches and chills. The patient was not diagnosed with COVID-19, prior to vaccination. The patient has been tested for COVID-19 since the vaccination. The patient underwent lab tests and procedures which included polymerase chain reaction: Negative on 24Jan2021 (COVID test type post vaccination: Nasal Swab). The events result in emergency room/department or urgent care visit. The patient did not receive any treatment for the events. The events were assessed as non-serious by the reporter. The outcome of the events was reported as recovered on an unspecified date in Jan2021.
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Muscle contractions involuntary, Paraesthesia, Tongue paralysis
Clinical narrative: Paresthesias in upper and lower extremities; left facial numbness and paresthesias; left facial weakness; fasciculations in abdomen and face; This is a spontaneous report from a contactable physician.   A 52-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), at the age of 52-year-old intramuscular on 21Jan2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. There were no covid prior vaccination and covid tested post vaccination. The patient experienced Paresthesias in upper and lower extremities, left facial numbness and paresthesias, left facial weakness, fasciculations in abdomen and face on 21Jan2021, resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Treatment was received including Prednisone.  The outcome of events was recovering.    Information on batch/lot number was requested.
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Asthenia, Burning sensation, Exercise tolerance decreased, Hypoaesthesia, Laboratory test
Clinical narrative: Paresthesias in upper and lower extremities; left facial numbness and paresthesias; left facial weakness; fasciculations in abdomen and face; This is a spontaneous report from a contactable physician.   A 52-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), at the age of 52-year-old intramuscular on 21Jan2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. There were no covid prior vaccination and covid tested post vaccination. The patient experienced Paresthesias in upper and lower extremities, left facial numbness and paresthesias, left facial weakness, fasciculations in abdomen and face on 21Jan2021, resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Treatment was received including Prednisone.  The outcome of events was recovering.    Information on batch/lot number was requested.
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Limb discomfort, Magnetic resonance imaging, Muscle contractions involuntary, Pain in extremity, Paraesthesia
Clinical narrative: Paresthesias in upper and lower extremities; left facial numbness and paresthesias; left facial weakness; fasciculations in abdomen and face; This is a spontaneous report from a contactable physician.   A 52-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), at the age of 52-year-old intramuscular on 21Jan2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. There were no covid prior vaccination and covid tested post vaccination. The patient experienced Paresthesias in upper and lower extremities, left facial numbness and paresthesias, left facial weakness, fasciculations in abdomen and face on 21Jan2021, resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Treatment was received including Prednisone.  The outcome of events was recovering.    Information on batch/lot number was requested.
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Tongue paralysis
Clinical narrative: Paresthesias in upper and lower extremities; left facial numbness and paresthesias; left facial weakness; fasciculations in abdomen and face; This is a spontaneous report from a contactable physician.   A 52-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), at the age of 52-year-old intramuscular on 21Jan2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. There were no covid prior vaccination and covid tested post vaccination. The patient experienced Paresthesias in upper and lower extremities, left facial numbness and paresthesias, left facial weakness, fasciculations in abdomen and face on 21Jan2021, resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Treatment was received including Prednisone.  The outcome of events was recovering.    Information on batch/lot number was requested.
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Paresthesias in upper and lower extremities; left facial numbness and paresthesias; left facial weakness; fasciculations in abdomen and face; This is a spontaneous report from a contactable physician.   A 52-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), at the age of 52-year-old intramuscular on 21Jan2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. There were no covid prior vaccination and covid tested post vaccination. The patient experienced Paresthesias in upper and lower extremities, left facial numbness and paresthesias, left facial weakness, fasciculations in abdomen and face on 21Jan2021, resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Treatment was received including Prednisone.  The outcome of events was recovering.    Information on batch/lot number was requested.
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Facial paresis, Hypoaesthesia, Muscle contractions involuntary, Paraesthesia
Clinical narrative: Paresthesias in upper and lower extremities; left facial numbness and paresthesias; left facial weakness; fasciculations in abdomen and face; This is a spontaneous report from a contactable physician.   A 52-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), at the age of 52-year-old intramuscular on 21Jan2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. There were no covid prior vaccination and covid tested post vaccination. The patient experienced Paresthesias in upper and lower extremities, left facial numbness and paresthesias, left facial weakness, fasciculations in abdomen and face on 21Jan2021, resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Treatment was received including Prednisone.  The outcome of events was recovering.    Information on batch/lot number was requested.
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Hypoaesthesia, Muscle contractions involuntary, Paraesthesia
Clinical narrative: Paresthesias in upper and lower extremities; left facial numbness and paresthesias; left facial weakness; fasciculations in abdomen and face; This is a spontaneous report from a contactable physician.   A 52-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), at the age of 52-year-old intramuscular on 21Jan2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. There were no covid prior vaccination and covid tested post vaccination. The patient experienced Paresthesias in upper and lower extremities, left facial numbness and paresthesias, left facial weakness, fasciculations in abdomen and face on 21Jan2021, resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Treatment was received including Prednisone.  The outcome of events was recovering.    Information on batch/lot number was requested.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal distension, Diarrhoea, Flatulence, Pain in extremity
Clinical narrative: Gas; bloating; diarrhea; This is a spontaneous report from a contactable consumer or other non hcp (patient).   A 64-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number:EN5318, batch and expiration date not reported), via an unspecified route of administration, administered on the left arm on 27Jan2021 08:30 (at the age of 64-years-old) at a single dose for COVID-19 immunisation. Medical history included high cholesterol and overweight. Concomitant medications included duloxetine hydrochloride (CYMBALTA), atorvastatin (manufacturer unknown), trazodone (manufacturer unknown), hydroxychloroquine (manufacturer unknown) all taken for an unspecified indication. The patient previously took sulfamethoxazole and trimethoprim  (BACTRIM DS) and experienced drug hypersensitivity. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19.  The patient experienced gas, bloating, and diarrhea on 27Jan2021 20:00. Events were assessed as non-serious. Treatment was not received for the events. The outcome of the events reported was recovered on an unspecified date.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal distension, Diarrhoea, Flatulence
Clinical narrative: Gas; bloating; diarrhea; This is a spontaneous report from a contactable consumer or other non hcp (patient).   A 64-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number:EN5318, batch and expiration date not reported), via an unspecified route of administration, administered on the left arm on 27Jan2021 08:30 (at the age of 64-years-old) at a single dose for COVID-19 immunisation. Medical history included high cholesterol and overweight. Concomitant medications included duloxetine hydrochloride (CYMBALTA), atorvastatin (manufacturer unknown), trazodone (manufacturer unknown), hydroxychloroquine (manufacturer unknown) all taken for an unspecified indication. The patient previously took sulfamethoxazole and trimethoprim  (BACTRIM DS) and experienced drug hypersensitivity. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19.  The patient experienced gas, bloating, and diarrhea on 27Jan2021 20:00. Events were assessed as non-serious. Treatment was not received for the events. The outcome of the events reported was recovered on an unspecified date.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Back pain, Bladder spasm, Computerised tomogram abdomen, Culture urine
Clinical narrative: dysuria; abdominal pain; pelvic pain; bladder spasms; left flank, low back and upper back pain; left flank, low back and upper back pain; headache; This is a spontaneous report received from a contactable nurse. A 63-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, lot number: EL0142) via an unspecified route of administration left arm on 14Jan2021 08:15 at single dose for COVID-19 immunization. Medical history was not provided. Concomitant medications included colecalciferol (VITAMIN D) and vitamin b complex. Patient previously took BNT162B2 (lot number: Eu1685) on 23Dec2020 07:45 to Left arm for COVID-19 immunization. On 26Jan2021 Lab data was reported as PCR test, Nasal Swab and Veritor rapid test results were negative. On 15Jan2021 the patient experienced with dysuria, abdominal pain, pelvic pain, bladder spasms, left flank, low back and upper back pain, headache. Patient received Bactrim, Toradol and Advil as treatment for events. Seriousness was reported as non-serious. Outcome of events was unknown.  No follow-up attempts are possible. No further information was provided.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Decreased appetite, Dysphagia, Dysuria, Fatigue, Flank pain
Clinical narrative: dysuria; abdominal pain; pelvic pain; bladder spasms; left flank, low back and upper back pain; left flank, low back and upper back pain; headache; This is a spontaneous report received from a contactable nurse. A 63-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, lot number: EL0142) via an unspecified route of administration left arm on 14Jan2021 08:15 at single dose for COVID-19 immunization. Medical history was not provided. Concomitant medications included colecalciferol (VITAMIN D) and vitamin b complex. Patient previously took BNT162B2 (lot number: Eu1685) on 23Dec2020 07:45 to Left arm for COVID-19 immunization. On 26Jan2021 Lab data was reported as PCR test, Nasal Swab and Veritor rapid test results were negative. On 15Jan2021 the patient experienced with dysuria, abdominal pain, pelvic pain, bladder spasms, left flank, low back and upper back pain, headache. Patient received Bactrim, Toradol and Advil as treatment for events. Seriousness was reported as non-serious. Outcome of events was unknown.  No follow-up attempts are possible. No further information was provided.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Full blood count, Headache, Metabolic function test, Pelvic pain, Pollakiuria
Clinical narrative: dysuria; abdominal pain; pelvic pain; bladder spasms; left flank, low back and upper back pain; left flank, low back and upper back pain; headache; This is a spontaneous report received from a contactable nurse. A 63-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, lot number: EL0142) via an unspecified route of administration left arm on 14Jan2021 08:15 at single dose for COVID-19 immunization. Medical history was not provided. Concomitant medications included colecalciferol (VITAMIN D) and vitamin b complex. Patient previously took BNT162B2 (lot number: Eu1685) on 23Dec2020 07:45 to Left arm for COVID-19 immunization. On 26Jan2021 Lab data was reported as PCR test, Nasal Swab and Veritor rapid test results were negative. On 15Jan2021 the patient experienced with dysuria, abdominal pain, pelvic pain, bladder spasms, left flank, low back and upper back pain, headache. Patient received Bactrim, Toradol and Advil as treatment for events. Seriousness was reported as non-serious. Outcome of events was unknown.  No follow-up attempts are possible. No further information was provided.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ultrasound abdomen, Ultrasound scan vagina, Urine analysis, Visual impairment
Clinical narrative: dysuria; abdominal pain; pelvic pain; bladder spasms; left flank, low back and upper back pain; left flank, low back and upper back pain; headache; This is a spontaneous report received from a contactable nurse. A 63-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, lot number: EL0142) via an unspecified route of administration left arm on 14Jan2021 08:15 at single dose for COVID-19 immunization. Medical history was not provided. Concomitant medications included colecalciferol (VITAMIN D) and vitamin b complex. Patient previously took BNT162B2 (lot number: Eu1685) on 23Dec2020 07:45 to Left arm for COVID-19 immunization. On 26Jan2021 Lab data was reported as PCR test, Nasal Swab and Veritor rapid test results were negative. On 15Jan2021 the patient experienced with dysuria, abdominal pain, pelvic pain, bladder spasms, left flank, low back and upper back pain, headache. Patient received Bactrim, Toradol and Advil as treatment for events. Seriousness was reported as non-serious. Outcome of events was unknown.  No follow-up attempts are possible. No further information was provided.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Back pain, Bladder spasm, Dysuria, Flank pain
Clinical narrative: dysuria; abdominal pain; pelvic pain; bladder spasms; left flank, low back and upper back pain; left flank, low back and upper back pain; headache; This is a spontaneous report received from a contactable nurse. A 63-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, lot number: EL0142) via an unspecified route of administration left arm on 14Jan2021 08:15 at single dose for COVID-19 immunization. Medical history was not provided. Concomitant medications included colecalciferol (VITAMIN D) and vitamin b complex. Patient previously took BNT162B2 (lot number: Eu1685) on 23Dec2020 07:45 to Left arm for COVID-19 immunization. On 26Jan2021 Lab data was reported as PCR test, Nasal Swab and Veritor rapid test results were negative. On 15Jan2021 the patient experienced with dysuria, abdominal pain, pelvic pain, bladder spasms, left flank, low back and upper back pain, headache. Patient received Bactrim, Toradol and Advil as treatment for events. Seriousness was reported as non-serious. Outcome of events was unknown.  No follow-up attempts are possible. No further information was provided.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Pelvic pain, Polymerase chain reaction, SARS-CoV-2 test
Clinical narrative: dysuria; abdominal pain; pelvic pain; bladder spasms; left flank, low back and upper back pain; left flank, low back and upper back pain; headache; This is a spontaneous report received from a contactable nurse. A 63-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, lot number: EL0142) via an unspecified route of administration left arm on 14Jan2021 08:15 at single dose for COVID-19 immunization. Medical history was not provided. Concomitant medications included colecalciferol (VITAMIN D) and vitamin b complex. Patient previously took BNT162B2 (lot number: Eu1685) on 23Dec2020 07:45 to Left arm for COVID-19 immunization. On 26Jan2021 Lab data was reported as PCR test, Nasal Swab and Veritor rapid test results were negative. On 15Jan2021 the patient experienced with dysuria, abdominal pain, pelvic pain, bladder spasms, left flank, low back and upper back pain, headache. Patient received Bactrim, Toradol and Advil as treatment for events. Seriousness was reported as non-serious. Outcome of events was unknown.  No follow-up attempts are possible. No further information was provided.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Feeling cold, Feeling hot, Pain, Paraesthesia
Clinical narrative: I started feeling pins and needles on my forearms/the pins and needs continued on my forearms and feet; burning sensation began throughout my legs and arms/hot sensation on and off; muscle spasms; cold sensations on my feet; The pins and needles continued along with cold and hot sensations throughout my arms and legs; At times my arms would feel heavy; This was very painful causing my muscles to be in extreme pain; Nerves were shaky/shakiness; painful and uncomfortable; painful and uncomfortable; This is a spontaneous report from a contactable consumer (Patient), the consumer reported for herself. A 38-Year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249), via an unspecified route of administration at the left arm on 19Jan2021 01:30 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient has no known allergies. Covid test result was Negative. On 21Jan2021, started feeling pins and needles on my forearms throughout the night. On 22Jan2021 the pins and needs continued on my forearms and feet, along with cold sensations on my feet. The pins and needles continued along with cold and hot sensations throughout my arms and legs from 21January - February 4. It was painful and uncomfortable on and throughout the day and nights. At times my arms would feel heavy and achy. This amount of pain led me to go to the ER on January 31, 2021. February 5-8 pins and needles were less. On February 13- 20 burning sensation began throughout my legs and arms. On 21Jan2021, This was very painful causing my muscles to be in extreme pain that led me to go to the Emergency room once again on 20February2021. February 22-24 I felt no burning sensation, but my nerves were shaky. On February 26 in the evening and at bedtime I experienced a hot sensation on and off throughout the night along with muscle spasms on 21Jan2021. Continued to experience burning, spasms and shakiness. Due to events treatment received IV treatment Neurotins. The outcome of the events was not recovered.  No follow-up attempts possible. No further information expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, COVID-19, Discomfort, Feeling of body temperature change, Investigation
Clinical narrative: I started feeling pins and needles on my forearms/the pins and needs continued on my forearms and feet; burning sensation began throughout my legs and arms/hot sensation on and off; muscle spasms; cold sensations on my feet; The pins and needles continued along with cold and hot sensations throughout my arms and legs; At times my arms would feel heavy; This was very painful causing my muscles to be in extreme pain; Nerves were shaky/shakiness; painful and uncomfortable; painful and uncomfortable; This is a spontaneous report from a contactable consumer (Patient), the consumer reported for herself. A 38-Year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249), via an unspecified route of administration at the left arm on 19Jan2021 01:30 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient has no known allergies. Covid test result was Negative. On 21Jan2021, started feeling pins and needles on my forearms throughout the night. On 22Jan2021 the pins and needs continued on my forearms and feet, along with cold sensations on my feet. The pins and needles continued along with cold and hot sensations throughout my arms and legs from 21January - February 4. It was painful and uncomfortable on and throughout the day and nights. At times my arms would feel heavy and achy. This amount of pain led me to go to the ER on January 31, 2021. February 5-8 pins and needles were less. On February 13- 20 burning sensation began throughout my legs and arms. On 21Jan2021, This was very painful causing my muscles to be in extreme pain that led me to go to the Emergency room once again on 20February2021. February 22-24 I felt no burning sensation, but my nerves were shaky. On February 26 in the evening and at bedtime I experienced a hot sensation on and off throughout the night along with muscle spasms on 21Jan2021. Continued to experience burning, spasms and shakiness. Due to events treatment received IV treatment Neurotins. The outcome of the events was not recovered.  No follow-up attempts possible. No further information expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Limb discomfort, Muscle spasms, Myalgia, Pain, Paraesthesia
Clinical narrative: I started feeling pins and needles on my forearms/the pins and needs continued on my forearms and feet; burning sensation began throughout my legs and arms/hot sensation on and off; muscle spasms; cold sensations on my feet; The pins and needles continued along with cold and hot sensations throughout my arms and legs; At times my arms would feel heavy; This was very painful causing my muscles to be in extreme pain; Nerves were shaky/shakiness; painful and uncomfortable; painful and uncomfortable; This is a spontaneous report from a contactable consumer (Patient), the consumer reported for herself. A 38-Year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249), via an unspecified route of administration at the left arm on 19Jan2021 01:30 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient has no known allergies. Covid test result was Negative. On 21Jan2021, started feeling pins and needles on my forearms throughout the night. On 22Jan2021 the pins and needs continued on my forearms and feet, along with cold sensations on my feet. The pins and needles continued along with cold and hot sensations throughout my arms and legs from 21January - February 4. It was painful and uncomfortable on and throughout the day and nights. At times my arms would feel heavy and achy. This amount of pain led me to go to the ER on January 31, 2021. February 5-8 pins and needles were less. On February 13- 20 burning sensation began throughout my legs and arms. On 21Jan2021, This was very painful causing my muscles to be in extreme pain that led me to go to the Emergency room once again on 20February2021. February 22-24 I felt no burning sensation, but my nerves were shaky. On February 26 in the evening and at bedtime I experienced a hot sensation on and off throughout the night along with muscle spasms on 21Jan2021. Continued to experience burning, spasms and shakiness. Due to events treatment received IV treatment Neurotins. The outcome of the events was not recovered.  No follow-up attempts possible. No further information expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Peripheral coldness, Tremor
Clinical narrative: I started feeling pins and needles on my forearms/the pins and needs continued on my forearms and feet; burning sensation began throughout my legs and arms/hot sensation on and off; muscle spasms; cold sensations on my feet; The pins and needles continued along with cold and hot sensations throughout my arms and legs; At times my arms would feel heavy; This was very painful causing my muscles to be in extreme pain; Nerves were shaky/shakiness; painful and uncomfortable; painful and uncomfortable; This is a spontaneous report from a contactable consumer (Patient), the consumer reported for herself. A 38-Year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249), via an unspecified route of administration at the left arm on 19Jan2021 01:30 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient has no known allergies. Covid test result was Negative. On 21Jan2021, started feeling pins and needles on my forearms throughout the night. On 22Jan2021 the pins and needs continued on my forearms and feet, along with cold sensations on my feet. The pins and needles continued along with cold and hot sensations throughout my arms and legs from 21January - February 4. It was painful and uncomfortable on and throughout the day and nights. At times my arms would feel heavy and achy. This amount of pain led me to go to the ER on January 31, 2021. February 5-8 pins and needles were less. On February 13- 20 burning sensation began throughout my legs and arms. On 21Jan2021, This was very painful causing my muscles to be in extreme pain that led me to go to the Emergency room once again on 20February2021. February 22-24 I felt no burning sensation, but my nerves were shaky. On February 26 in the evening and at bedtime I experienced a hot sensation on and off throughout the night along with muscle spasms on 21Jan2021. Continued to experience burning, spasms and shakiness. Due to events treatment received IV treatment Neurotins. The outcome of the events was not recovered.  No follow-up attempts possible. No further information expected.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chest discomfort, Dizziness, Dyspnoea, Fatigue
Clinical narrative: Heartbeat 15-20 bpm higher than my normal; Chest tightness; Difficulty breathing; Dizziness; Injection site pain; Headache; Tiredness/ Extreme exhaustion; Muscle pain; Joint pain; Fever; Feeling unwell; Swollen lymph nodes; This is a spontaneous report received from a contactable consumer (patient). A 30-year-old female non-pregnant patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EL9261), via an unspecified route of administration on Arm Left on 25Jan2021 18:30 as single dose for COVID-19 immunisation in hospital. Medical history included seasonal allergy and Known allergies. Concomitant medications included unspecified medications received within two weeks. The patient did not receive other vaccines within four weeks. The patient not had COVID prior vaccination. The patient was not tested for COVID post vaccination. On 25Jan2021 22:30, the patient was totally fine for 4 hours. After 4 hours she started to get injection site pain, headache, tiredness, muscle pain, joint pain, fever, feeling unwell, and swollen lymph nodes. All of this lasted for 2 days. At the end of the 24 hours mark (on 26Jan2021), she started having a heartbeat 15-20 bpm higher than her normal, chest tightness, difficulty breathing, and dizziness. She was now 3.5 days post vaccine dose 1 and still having all of the symptoms in her last sentence plus extreme exhaustion, muscle pain, and fever. The events result in doctor or other healthcare professional office/clinic visit. Unspecified therapeutic measures were taken as a for all the events. The outcome of the events was reported as not recovered.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Heart rate increased, Injection site pain, Lymphadenopathy, Malaise
Clinical narrative: Heartbeat 15-20 bpm higher than my normal; Chest tightness; Difficulty breathing; Dizziness; Injection site pain; Headache; Tiredness/ Extreme exhaustion; Muscle pain; Joint pain; Fever; Feeling unwell; Swollen lymph nodes; This is a spontaneous report received from a contactable consumer (patient). A 30-year-old female non-pregnant patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EL9261), via an unspecified route of administration on Arm Left on 25Jan2021 18:30 as single dose for COVID-19 immunisation in hospital. Medical history included seasonal allergy and Known allergies. Concomitant medications included unspecified medications received within two weeks. The patient did not receive other vaccines within four weeks. The patient not had COVID prior vaccination. The patient was not tested for COVID post vaccination. On 25Jan2021 22:30, the patient was totally fine for 4 hours. After 4 hours she started to get injection site pain, headache, tiredness, muscle pain, joint pain, fever, feeling unwell, and swollen lymph nodes. All of this lasted for 2 days. At the end of the 24 hours mark (on 26Jan2021), she started having a heartbeat 15-20 bpm higher than her normal, chest tightness, difficulty breathing, and dizziness. She was now 3.5 days post vaccine dose 1 and still having all of the symptoms in her last sentence plus extreme exhaustion, muscle pain, and fever. The events result in doctor or other healthcare professional office/clinic visit. Unspecified therapeutic measures were taken as a for all the events. The outcome of the events was reported as not recovered.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Heartbeat 15-20 bpm higher than my normal; Chest tightness; Difficulty breathing; Dizziness; Injection site pain; Headache; Tiredness/ Extreme exhaustion; Muscle pain; Joint pain; Fever; Feeling unwell; Swollen lymph nodes; This is a spontaneous report received from a contactable consumer (patient). A 30-year-old female non-pregnant patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EL9261), via an unspecified route of administration on Arm Left on 25Jan2021 18:30 as single dose for COVID-19 immunisation in hospital. Medical history included seasonal allergy and Known allergies. Concomitant medications included unspecified medications received within two weeks. The patient did not receive other vaccines within four weeks. The patient not had COVID prior vaccination. The patient was not tested for COVID post vaccination. On 25Jan2021 22:30, the patient was totally fine for 4 hours. After 4 hours she started to get injection site pain, headache, tiredness, muscle pain, joint pain, fever, feeling unwell, and swollen lymph nodes. All of this lasted for 2 days. At the end of the 24 hours mark (on 26Jan2021), she started having a heartbeat 15-20 bpm higher than her normal, chest tightness, difficulty breathing, and dizziness. She was now 3.5 days post vaccine dose 1 and still having all of the symptoms in her last sentence plus extreme exhaustion, muscle pain, and fever. The events result in doctor or other healthcare professional office/clinic visit. Unspecified therapeutic measures were taken as a for all the events. The outcome of the events was reported as not recovered.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Heart rate, Heart rate increased, Lymphadenopathy, Malaise
Clinical narrative: Heartbeat 15-20 bpm higher than my normal; Chest tightness; Difficulty breathing; Dizziness; Injection site pain; Headache; Tiredness/ Extreme exhaustion; Muscle pain; Joint pain; Fever; Feeling unwell; Swollen lymph nodes; This is a spontaneous report received from a contactable consumer (patient). A 30-year-old female non-pregnant patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EL9261), via an unspecified route of administration on Arm Left on 25Jan2021 18:30 as single dose for COVID-19 immunisation in hospital. Medical history included seasonal allergy and Known allergies. Concomitant medications included unspecified medications received within two weeks. The patient did not receive other vaccines within four weeks. The patient not had COVID prior vaccination. The patient was not tested for COVID post vaccination. On 25Jan2021 22:30, the patient was totally fine for 4 hours. After 4 hours she started to get injection site pain, headache, tiredness, muscle pain, joint pain, fever, feeling unwell, and swollen lymph nodes. All of this lasted for 2 days. At the end of the 24 hours mark (on 26Jan2021), she started having a heartbeat 15-20 bpm higher than her normal, chest tightness, difficulty breathing, and dizziness. She was now 3.5 days post vaccine dose 1 and still having all of the symptoms in her last sentence plus extreme exhaustion, muscle pain, and fever. The events result in doctor or other healthcare professional office/clinic visit. Unspecified therapeutic measures were taken as a for all the events. The outcome of the events was reported as not recovered.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: Heartbeat 15-20 bpm higher than my normal; Chest tightness; Difficulty breathing; Dizziness; Injection site pain; Headache; Tiredness/ Extreme exhaustion; Muscle pain; Joint pain; Fever; Feeling unwell; Swollen lymph nodes; This is a spontaneous report received from a contactable consumer (patient). A 30-year-old female non-pregnant patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EL9261), via an unspecified route of administration on Arm Left on 25Jan2021 18:30 as single dose for COVID-19 immunisation in hospital. Medical history included seasonal allergy and Known allergies. Concomitant medications included unspecified medications received within two weeks. The patient did not receive other vaccines within four weeks. The patient not had COVID prior vaccination. The patient was not tested for COVID post vaccination. On 25Jan2021 22:30, the patient was totally fine for 4 hours. After 4 hours she started to get injection site pain, headache, tiredness, muscle pain, joint pain, fever, feeling unwell, and swollen lymph nodes. All of this lasted for 2 days. At the end of the 24 hours mark (on 26Jan2021), she started having a heartbeat 15-20 bpm higher than her normal, chest tightness, difficulty breathing, and dizziness. She was now 3.5 days post vaccine dose 1 and still having all of the symptoms in her last sentence plus extreme exhaustion, muscle pain, and fever. The events result in doctor or other healthcare professional office/clinic visit. Unspecified therapeutic measures were taken as a for all the events. The outcome of the events was reported as not recovered.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Lymphadenopathy, Neck pain
Clinical narrative: she started feeling more severe neck pain; swollen lymph nodes on her left collar bone and neck area; This is a spontaneous report from a contactable consumer, the patient. A 26-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL0142), via an unspecified route of administration, in the left arm on 27Jan2021 16:00 (at the age of 26-years-old) as single dose for COVID-19 immunization. The patient medical history reported as none. The patient had no History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available). The patient concomitant medications reported as none. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously recived first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL1284, Expiration Date: Unknown), via intramuscular route of administration, in the left arm on 06Jan2021 2:30PM (at the age of 26-years-old) as single dose for COVID-19 immunization. The patient did not visited to emergency room or physician office. The patient did not underwent lab test. It was reported that the had vaccine last week 27Jan2021. 3-4 days later she started feeling more severe neck pain, like it hurt to move her neck and head, and then the next day she noticed swollen lymph nodes on her left collar bone and neck area." It was questin was this normal. She said she read online where some people experienced swollen lymph nodes in the armpit area on the left side. She said she didnot see anything about swollen lymph nodes above the collar bone area. Caller asked if BNT162B2 vaccine was causing her swollen lymph nodes, and if so, how long should she expect the swollen lymph nodes to last. No treatment was received for the swollen lymph nodes on my left collar bone and neck. Outcome of the event swollen lymph nodes on my left collar bone and neck area was not recovered and unknown for other event.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy, Neck pain
Clinical narrative: she started feeling more severe neck pain; swollen lymph nodes on her left collar bone and neck area; This is a spontaneous report from a contactable consumer, the patient. A 26-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL0142), via an unspecified route of administration, in the left arm on 27Jan2021 16:00 (at the age of 26-years-old) as single dose for COVID-19 immunization. The patient medical history reported as none. The patient had no History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available). The patient concomitant medications reported as none. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously recived first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL1284, Expiration Date: Unknown), via intramuscular route of administration, in the left arm on 06Jan2021 2:30PM (at the age of 26-years-old) as single dose for COVID-19 immunization. The patient did not visited to emergency room or physician office. The patient did not underwent lab test. It was reported that the had vaccine last week 27Jan2021. 3-4 days later she started feeling more severe neck pain, like it hurt to move her neck and head, and then the next day she noticed swollen lymph nodes on her left collar bone and neck area." It was questin was this normal. She said she read online where some people experienced swollen lymph nodes in the armpit area on the left side. She said she didnot see anything about swollen lymph nodes above the collar bone area. Caller asked if BNT162B2 vaccine was causing her swollen lymph nodes, and if so, how long should she expect the swollen lymph nodes to last. No treatment was received for the swollen lymph nodes on my left collar bone and neck. Outcome of the event swollen lymph nodes on my left collar bone and neck area was not recovered and unknown for other event.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure measurement, Dizziness, Dry mouth, Gait disturbance, Headache
Clinical narrative: vertigo; 101 fever; Sweats; This is a spontaneous report from a Pfizer Safety Call Centre. A contactable consumer reported for herself that a female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on unspecified date at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient reported no events with second shot but with first shot the patient had vertigo, a 101 fever and sweats on the second day. The patient took the second shot anyway but had no symptoms with it. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypertension, Malaise, Presyncope, Vertigo
Clinical narrative: vertigo; 101 fever; Sweats; This is a spontaneous report from a Pfizer Safety Call Centre. A contactable consumer reported for herself that a female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on unspecified date at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient reported no events with second shot but with first shot the patient had vertigo, a 101 fever and sweats on the second day. The patient took the second shot anyway but had no symptoms with it. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Hyperhidrosis, Pyrexia, Vertigo
Clinical narrative: vertigo; 101 fever; Sweats; This is a spontaneous report from a Pfizer Safety Call Centre. A contactable consumer reported for herself that a female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on unspecified date at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient reported no events with second shot but with first shot the patient had vertigo, a 101 fever and sweats on the second day. The patient took the second shot anyway but had no symptoms with it. The outcome of the event was unknown.  Information on the lot/batch number has been requested.